New Equilibrium

New Equilibrium is a company that focuses on rational drug design targeting intrinsically disordered proteins (IDPs). The company’s platform uncovers previously inaccessible opportunities for structure-based design by integrating AI and biophysics to reveal conformational states of shape-shifting proteins that are experimentally invisible. This advanced technology enables the rational design of drugs targeting intrinsically disordered proteins, which include many targets associated with cancer, neurodegeneration, and other indications.